Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/CANTARGIA-AB-31837413/nieuws/Cantargia-presenteert-nieuwe-klinische-gegevens-die-de-antitumoractiviteit-van-nadunolimab-en-de-sle-44941169/?utm_source=whatsapp&utm_medium=social&utm_campaign=share